litlas
ログインアカウント作成

Michael A. Carducci

1995–2026 年に発表

212
論文数
48,143
被引用数
105
h 指数
206
i10 指数

被引用数

Michael A. Carducci の年別被引用数1992 年: 被引用 2 件1996 年: 被引用 2 件1997 年: 被引用 3 件1998 年: 被引用 19 件1999 年: 被引用 21 件2000 年: 被引用 38 件2001 年: 被引用 61 件2002 年: 被引用 75 件2003 年: 被引用 81 件2004 年: 被引用 119 件2005 年: 被引用 143 件2006 年: 被引用 164 件2007 年: 被引用 243 件2008 年: 被引用 279 件2009 年: 被引用 328 件2010 年: 被引用 328 件2011 年: 被引用 362 件2012 年: 被引用 298 件2013 年: 被引用 374 件2014 年: 被引用 342 件2015 年: 被引用 404 件2016 年: 被引用 478 件2017 年: 被引用 497 件2018 年: 被引用 486 件2019 年: 被引用 1,554 件2020 年: 被引用 1,679 件2021 年: 被引用 1,765 件2022 年: 被引用 1,338 件2023 年: 被引用 941 件2024 年: 被引用 1,481 件2025 年: 被引用 611 件2026 年: 被引用 19 件1993〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,624 件、この内訳の 28%イギリス: 引用元論文 1,417 件、この内訳の 7.1%中国: 引用元論文 1,343 件、この内訳の 6.7%ドイツ: 引用元論文 1,174 件、この内訳の 5.8%イタリア: 引用元論文 1,056 件、この内訳の 5.3%カナダ: 引用元論文 1,038 件、この内訳の 5.2%フランス: 引用元論文 813 件、この内訳の 4.1%オーストラリア: 引用元論文 710 件、この内訳の 3.5%オランダ: 引用元論文 600 件、この内訳の 3%日本: 引用元論文 582 件、この内訳の 2.9%スペイン: 引用元論文 581 件、この内訳の 2.9%スイス: 引用元論文 486 件、この内訳の 2.4%
0%28%その他 23.1%

機関

分野

  • Medicine63.7%
  • Biochemistry, Genetics and Molecular Biology22.2%
  • Psychology7.4%
  • Immunology and Microbiology2.9%
  • Neuroscience0.5%
  • Materials Science0.5%
  • その他2.8%

トピック

  • Prostate Cancer Treatment and Research11.2%
  • Prostate Cancer Diagnosis and Treatment5.9%
  • Radiopharmaceutical Chemistry and Applications3.2%
  • Renal cell carcinoma treatment3.2%
  • Cancer Immunotherapy and Biomarkers3.1%
  • Psychedelics and Drug Studies2.5%
  • その他70.9%

共著者

全論文

検索で開く
  1. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

    著者: Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards, Brian D. Richards, Mary P Cosimano, Margaret A. Klinedinst - Journal of Psychopharmacology 2016 被引用: 2,163

  2. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    著者: Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia S. Higano, Ethan Basch, Karim Fizazi, Emmanuel S. Antonarakis, Tomasz M. Beer, Michael A. Carducci, Kim N., Paul G. Corn, Johann S. de Bono, Robert Dreicer, Daniel J. George, Elisabeth I. Heath, Maha Hussain, Wm. Kevin Kelly, Glenn Liu, Christopher J. Logothetis, David M. Nanus, Mark N. Stein, Dana E. Rathkopf, Susan F. Slovin, Charles J. Ryan, Oliver Sartor, Eric J. Small, Matthew Raymond Smith, Cora N. Sternberg, Mary-Ellen Taplin, George Wilding, Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603

  3. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

    著者: Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard, Mario A. Eisenberger, Yu-Ning Wong, Noah M. Hahn, Manish Kohli, Matthew M. Cooney, Robert Dreicer, Nicholas J. Vogelzang, Joel Picus, Daniel H. Shevrin, Maha Hussain, Jorge A. García, Robert S. DiPaola - New England Journal of Medicine 2015 被引用: 2,835

  4. AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

    著者: Emmanuel S. Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mari Nakazawa, Jeffrey C. Roeser, Yan Chen, Tabrez A. Mohammad, Yidong Chen, Helen Fedor, Tamara L. Lotan, Qizhi Zheng, Angelo M. De Marzo, John T. Isaacs, William B. Isaacs, Rosa Nadal, Channing J. Paller, Samuel R. Denmeade, Michael A. Carducci, Mario A. Eisenberger, Jun Luo - New England Journal of Medicine 2014 被引用: 2,687

  5. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

    著者: Ryan Phillips, William Y. Shi, Matthew P. Deek, Noura Radwan, Su Jin Lim, Emmanuel S. Antonarakis, Steven P. Rowe, Ashley E. Ross, Michael A. Gorin, Curtiland Deville, Stephen Greco, Hailun Wang, Samuel R. Denmeade, Channing J. Paller, Shirl Dipasquale, Theodore L. DeWeese, Daniel Y. Song, Hao Wang, Michael A. Carducci, Kenneth J. Pienta, Martin G. Pomper, Adam P. Dicker, Mario A. Eisenberger, Ash A. Alizadeh, Maximilian Diehn, Phuoc T. Tran - JAMA Oncology 2020 被引用: 1,140

  6. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

    著者: Christos E. Kyriakopoulos, Yu‐Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard, Noah M. Hahn, Daniel H. Shevrin, Robert Dreicer, Maha Hussain, Mario A. Eisenberger, Manish Kohli, Elizabeth R. Plimack, Nicholas J. Vogelzang, Joel Picus, Matthew M. Cooney, Jorge A. García, Robert S. DiPaola, Christopher J. Sweeney - Journal of Clinical Oncology 2018 被引用: 1,106

  7. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

    著者: Robert J. Motzer, Brian I. Rini, David F. McDermott, Osvaldo Arén Frontera, Hans J. Hammers, Michael A. Carducci, Pamela Salman, Bernard Escudier, Benoit Beuselinck, Asim Amin, Camillo Porta, Saby George, Victoria Neiman, Sergio Bracarda, Scott S. Tykodi, Philippe Barthélémy, Raya Leibowitz‐Amit, Elizabeth R. Plimack, Sjoukje F. Oosting, Bruce G. Redman, Bohuslav Melichar, Thomas Powles, Paul Nathan, Stéphane Oudard, David Pook, Toni K. Choueiri, Frede Donskov, Marc‐Oliver Grimm, Howard Gurney, Daniel Y.C. Heng, Christian Kollmannsberger, Michael R. Harrison, Yoshihiko Tomita, Ignacio Durán, Viktor Grünwald, M. Brent McHenry, Sabeen Mekan, Nizar M. Tannir - The Lancet Oncology 2019 被引用: 780

  8. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

    著者: Howard I. Scher, Susan Halabi, Ian F. Tannock, Michael J. Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia S. Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip W. Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, Maha Hussain - Journal of Clinical Oncology 2008 被引用: 2,241

  9. Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

    著者: Robert J. Motzer, Bernard Escudier, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Elizabeth R. Plimack, Giuseppe Procopio, David F. McDermott, Daniel Castellano, Toni K. Choueiri, Frede Donskov, Howard Gurney, Stéphane Oudard, Martin Eduardo Richardet, Katriina Peltola, Ajjai Alva, Michael A. Carducci, John Wagstaff, Christine Chevreau, Satoshi Fukasawa, Yoshihiko Tomita, Thomas Gauler, Christian Kollmannsberger, Fabio A.B. Schutz, James Larkin, David Cella, M. Brent McHenry, Shruti Shally Saggi, Nizar M. Tannir - Cancer 2020 被引用: 337

  10. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

    著者: Karim Fizazi, Michael A. Carducci, Matthew R. Smith, Ronaldo Damião, Janet E. Brown, Lawrence I. Karsh, Piotr Milecki, Neal D. Shore, Michael Rader, Huei Wang, Qi Jiang, Sylvia Tadros, Roger Dansey, Carsten Goessl - The Lancet 2011 被引用: 1,965

  11. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

    著者: Gary R. Hudes, Michael A. Carducci, Piotr Tomczak, Janice Dutcher, Robert A. Figlin, Anil Kapoor, Elżbieta Starosławska, Jeffrey A. Sosman, David McDermott, I. Bodrogi, Zoran Kovačević, Vladimir Lesovoy, Ingo G.H. Schmidt‐Wolf, О. Л. Барбараш, Erhan Gökmen, Timothy E. O’Toole, Stephanie Lustgarten, Laurence Moore, Robert J. Motzer - New England Journal of Medicine 2007 被引用: 3,647

  12. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

    著者: Naomi B. Haas, Judith Manola, Robert G. Uzzo, Keith T. Flaherty, Christopher G. Wood, Christopher J. Kane, Michael A.S. Jewett, Janice P. Dutcher, Michael B. Atkins, Michael Pins, George Wilding, David Cella, Lynne I. Wagner, Surena F. Matin, Timothy M. Kuzel, Wade J. Sexton, Yu-Ning Wong, Toni K. Choueiri, Роберто Пили, Igor Puzanov, Manish Kohli, Walter M. Stadler, Michael A. Carducci, Robert Coomes, Robert S. DiPaola - The Lancet 2016 被引用: 638

  13. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide

    著者: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, Hao Wang, Yan Chen, Yezi Zhu, John L. Silberstein, Maritza N. Taylor, Benjamin L. Maughan, Samuel R. Denmeade, Kenneth J. Pienta, Channing J. Paller, Michael A. Carducci, Mario A. Eisenberger, Jun Luo - Journal of Clinical Oncology 2017 被引用: 472

  14. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

    著者: Rong Na, Shusen Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M. Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz, Kamalakar Gulukota, Donald L. Helseth, Margo Quinn, Elizabeth Humphries, Kathleen E. Wiley, Sarah D. Isaacs, Yishuo Wu, Xu Liu, Ning Zhang, Chi-Hsiung Wang, Janardan D. Khandekar, Peter J. Hulick, Daniel H. Shevrin, Kathleen A. Cooney, Zhoujun Shen, Alan W. Partin, H. Ballentine Carter, Michael A. Carducci, Mario A. Eisenberger, S. Denmeade, Michael McGuire, Patrick C. Walsh, Brian T. Helfand, Charles B. Brendler, Qiang Ding, Jianfeng Xu, William B. Isaacs - European Urology 2016 被引用: 341

  15. Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies

    著者: Gwénaëlle Gravis, Jean‐Marie Boher, Yu‐Hui Chen, Glenn Liu, Karim Fizazi, Michael A. Carducci, Stéphane Oudard, Florence Joly, David Jarrard, M. Soulié, Mario Eisenberger, Muriel Habibian, Robert Dreicer, Jorge A. García, Maha H.M. Hussain, Manish Kohli, Nicholas J. Vogelzang, Joel Picus, Robert S. DiPaola, Christopher J. Sweeney - European Urology 2018 被引用: 247

  16. Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, Hao Wang, Yan Chen, Mari Nakazawa, Rosa Nadal, Channing J. Paller, Samuel R. Denmeade, Michael A. Carducci, Mario A. Eisenberger, Jun Luo - JAMA Oncology 2015 被引用: 616

  17. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma

    著者: Vitaly Margulis, Mäneka Puligandla, Edouard J. Trabulsi, Elizabeth R. Plimack, Elizabeth R. Kessler, Surena F. Matin, Guilherme Godoy, Ajjai Alva, Noah M. Hahn, Michael A. Carducci, Jean Hoffman‐Censits, Nirmish Singla, Antony Ruggeri, Leslie Howard, John McCann, Scott E. Delacroix, Matthew Matthew, Yagnesh Oza, Jennifer Wang, Benjamin A. Gartrell, Maha Hussain, Marc Matrana, Sam Benjamin, Guru Sonpavde, Elaine T. Lam, Brandon Bernard, Yousef Zakharia, Sarah E. Taylor, Matthew I. Milowsky, Sofia Ghani, Sindhu Singh, Kevin M. Kane, Yull Arriaga, Amee Morgans, David D. Chism - The Journal of Urology 2019 被引用: 133

  18. A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination

    著者: Channing J. Paller, Michelle A. Rudek, Xian Zhou, William D. Wagner, Tamaro Hudson, Nicole M. Anders, Hans J. Hammers, Donna Dowling, Serina King, Emmanuel S. Antonarakis, Charles G. Drake, Mario A. Eisenberger, Samuel R. Denmeade, Gary L. Rosner, Michael A. Carducci - The Prostate 2015 被引用: 125

  19. Engineering a Prostate-Specific Membrane Antigen–Activated Tumor Endothelial Cell Prodrug for Cancer Therapy

    著者: Samuel R. Denmeade, Annastasiah Mhaka, Dina Rosen, W. Nathaniel Brennen, Susan L. Dalrymple, Ingrid Dach, Claus Olesen, Bora Gürel, Angelo M. De Marzo, George Wilding, Michael A. Carducci, Craig A. Dionne, Jesper V. Møller, Poul Nissen, S. Brøgger Christensen, John T. Isaacs - Science Translational Medicine 2012 被引用: 217

  20. TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer

    著者: Samuel R. Denmeade, Hao Wang, Neeraj Agarwal, David C. Smith, Michael T. Schweizer, Mark N. Stein, Vasileios J. Assikis, Przemyslaw Twardowski, Thomas W. Flaig, Russell Z. Szmulewitz, Jeffrey M. Holzbeierlein, Ralph J. Hauke, Guru Sonpavde, Jorge A. García, Arif Hussain, Oliver Sartor, Shifeng Mao, Harry Cao, Wei Fu, Ting Wang, Rehab Abdallah, Su Jin Lim, Vanessa Bolejack, Channing J. Paller, Michael A. Carducci, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis - Journal of Clinical Oncology 2021 被引用: 137

  21. Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

    著者: Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli - Journal for ImmunoTherapy of Cancer 2018 被引用: 99

  22. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

    著者: Wennuan Liu, Sari Laitinen, Sofia Khan, Mauno Vihinen, Jeanne Kowalski, Guoqiang Yu, Li Chen, Charles M. Ewing, Mario A. Eisenberger, Michael A. Carducci, William G. Nelson, Srinivasan Yegnasubramanian, Jun Luo, Yue Wang, Jianfeng Xu, William B. Isaacs, Tapio Visakorpi, G. Steven Bova - Nature Medicine 2009 被引用: 660

  23. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation

    著者: Andres Correa, Opeyemi A. Jegede, Naomi B. Haas, Keith T. Flaherty, Michael R. Pins, Edward M. Messing, Judith Manola, Christopher G. Wood, Christopher J. Kane, Michael A.S. Jewett, Janice P. Dutcher, Robert S. DiPaola, Michael A. Carducci, Robert G. Uzzo - Journal of Clinical Oncology 2019 被引用: 153

  24. Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

    著者: Eugene Shenderov, Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan, Alice Jordan, Donna Dowling, Rana Harb, Joseph D. Schonhoft, Adam Jendrisak, Michael A. Carducci, Mario A. Eisenberger, James R. Eshleman, Jun Luo, Charles G. Drake, Drew M. Pardoll, Emmanuel S. Antonarakis - The Prostate 2021 被引用: 69